| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Influence of laminopathies on wnt signaling 0.8567919823656667 2.957607724804313 0.0031003639582753 0.837915180814709 0.6056044265164613 10 O75844,P49354,O60725 3 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.7139507036781781 2.568356569409479 0.0102181988719678 0.9975670898495788 0.747173718747776 16 P50402,O75844,P49354,O60725 4 |
| Endothelin pathways 0.8266922096575866 2.37440292768511 0.0175773574141298 0.9999693210173286 0.747173718747776 7 P42892 1 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.8581457565969731 2.223064658029601 0.0262114403542415 0.9999998261016504 0.747173718747776 5 O60725 1 |
| Cholesterol biosynthesis with skeletal dysplasias 0.8501295168825527 2.1897524620372986 0.0285421940664039 0.9999999572997724 0.747173718747776 5 Q15392 1 |
| Spinal cord injury 0.6335357388932203 2.1367756062150023 0.0326162471198094 0.9999999963617674 0.747173718747776 15 P14174,P08670,Q9NQC3,P17931,P04083,P06493,P61586 7 |
| Progeriaassociated lipodystrophy 0.682353304369158 2.0931229910325917 0.0363381768452297 0.9999999996199442 0.747173718747776 10 P46063,O75844,P49354,O60725 4 |
| Allograft rejection 0.6902407468951713 2.0285358594934397 0.0425055872887916 0.9999999999911724 0.747173718747776 9 P08183,P08670 2 |
| Familial partial lipodystrophy fpld 0.7479788618819313 2.017651315713383 0.0436275884746131 0.9999999999955592 0.747173718747776 7 P49354,O60725 2 |
| Pdgf pathway 0.666290764446367 2.0090731573239484 0.0445293758726164 0.9999999999974452 0.747173718747776 10 P40763,P00403,P62993,P61586,P42224 5 |
| Mthfr deficiency 0.7846031331514769 2.002909169202217 0.0451870387334949 0.9999999999982934 0.747173718747776 6 P49419 1 |
| Myometrial relaxation and contraction pathways 0.5935755254646629 1.9275795744499085 0.053907441500582 0.999999999999992 0.747173718747776 14 P78417,P62258,P0DP25,P10644,Q99439,Q04917,P63104,P61981 8 |
| Wnt signaling pathway 0.727861906698567 1.924261372843985 0.0543218297293317 0.999999999999994 0.747173718747776 7 Q13363 1 |
| Methionine de novo and salvage pathway 0.7625852871925826 1.90616193186108 0.0566291995732846 0.9999999999999986 0.747173718747776 6 Q13126 1 |
| Oxidation by cytochrome p450 0.8088193102394552 1.814947307304161 0.0695320075162559 1.0 0.747173718747776 4 O43169 1 |
| Ethanol effects on histone modifications 0.6296596620305657 1.8146915038616065 0.0695713314471917 1.0 0.747173718747776 10 P00374,Q96KQ7,P41440 3 |
| Neural crest cell migration in cancer 0.7591342197101353 1.803563018749025 0.0712998378759797 1.0 0.747173718747776 5 P40763,P61586,Q99523 3 |
| Nanomaterial induced apoptosis 0.8044093384275736 1.7968005401928078 0.0723672905913854 1.0 0.747173718747776 4 Q9NR28 1 |
| Ciliopathies 0.6056640953423993 1.7885790981570335 0.0736826265461259 1.0 0.747173718747776 11 O43924,Q15555 2 |
| Interleukin11 signaling pathway 0.6197188878452724 1.7613208046362796 0.0781841207105333 1.0 0.747173718747776 10 P40763,Q15257,P62993,Q15418,P42224 5 |
| Nucleotide metabolism 0.5790562062015989 1.7480394994234767 0.0804571879626769 1.0 0.747173718747776 12 P00374,P31350 2 |
| G1 to s cell cycle control 0.5780173258778497 1.7336125688253818 0.0829868488469109 1.0 0.747173718747776 18 Q07864,P49736,P49643,P25205,P33993,Q14566,P06400,P06493,P11802,P15927 10 |
| Autophagy 0.7412802440383577 1.726174916076039 0.0843159493079359 1.0 0.747173718747776 5 Q96B36,Q9NT62 2 |
| Pathogenic escherichia coli infection 0.5870281277582657 1.7155314261828132 0.0862478387594074 1.0 0.747173718747776 21 P07437,Q9BVA1,Q13464,Q9BUF5,P68371,Q13885,P61586,P15311 8 |
| Cholesterol biosynthesis pathway 0.625164668416051 1.6934749525630508 0.0903650985935076 1.0 0.747173718747776 9 P37268,Q16850 2 |
| Pancreatic adenocarcinoma pathway 0.5580815254115766 1.688851618580843 0.0912478689013238 1.0 0.747173718747776 15 P40763,P30086,Q13177,P06400,P11802,P61586,P42224 7 |
| Wnt signaling pathway and pluripotency 0.5674594881460795 1.6805381096202383 0.0928526659925514 1.0 0.747173718747776 12 P30154,Q13363,P61586,Q15257 4 |
| Map3k1 role in promoting and blocking gonadal determination 0.7304349494805369 1.678938429042549 0.0931640440411194 1.0 0.747173718747776 5 P61586 1 |
| Ccl18 signaling pathway 0.6757629076544385 1.6785163820384017 0.0932463351033456 1.0 0.747173718747776 7 P08670,Q86UE4,P00403,P33176 4 |
| Mitochondrial complex iv assembly 0.6367840869526117 1.663515608910319 0.0962092690174456 1.0 0.747173718747776 8 P14406 1 |
| Dna mismatch repair 0.5445220145161346 1.632480310795227 0.1025783429137432 1.0 0.747173718747776 14 P28340,Q9UQ84,P41440,P15927,P43246 5 |
| Il10 antiinflammatory signaling pathway 0.7641535149210452 1.6299905145781637 0.1031035017363728 1.0 0.747173718747776 4 P09601,P42224 2 |
| Neural crest cell migration during development 0.7528908165304755 1.5829824156168706 0.1134254723770205 1.0 0.747173718747776 4 P40763,P61586 2 |
| Il5 signaling pathway 0.5857351759193505 1.577048565218902 0.1147843508106796 1.0 0.747173718747776 10 P40763,P62993,Q15418,P42224 4 |
| Folate metabolism 0.5495012580316126 1.5753055550747064 0.1151859323655648 1.0 0.747173718747776 12 P00374,Q8WTV0,P41440 3 |
| Epo receptor signaling 0.6864195015938165 1.5650138966964409 0.1175796509097044 1.0 0.747173718747776 6 P40763,P62993,P42224 3 |
| Il9 signaling pathway 0.6864195015938165 1.5650138966964409 0.1175796509097044 1.0 0.747173718747776 6 P40763,P62993,P42224 3 |
| 1q211 copy number variation syndrome 0.6501724880913069 1.555970260359843 0.1197151643767671 1.0 0.747173718747776 7 Q9NPH0 1 |
| 15q112 copy number variation syndrome 0.7463175122749522 1.5554874302635031 0.119830025912456 1.0 0.747173718747776 4 Q06787,Q7L576,Q9BSJ2 3 |
| Pdgfrbeta pathway 0.6826072107620343 1.5477095798596447 0.1216922345761584 1.0 0.747173718747776 6 P40763,P62993,P42224 3 |
| Sphingolipid metabolism overview 0.6465132803287074 1.538361736793585 0.1239601923839346 1.0 0.747173718747776 7 P27544,Q96G23,Q06136 3 |
| Sphingolipid metabolism integrated pathway 0.6465132803287074 1.538361736793585 0.1239601923839346 1.0 0.747173718747776 7 P27544,Q96G23,Q06136 3 |
| Statin inhibition of cholesterol production 0.851942740286288 1.525269184313138 0.1271919705999571 1.0 0.747173718747776 3 P37268,Q8WTV0 2 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.7313673888823159 1.492807336503175 0.1354876263253834 1.0 0.747173718747776 4 P07099 1 |
| Il7 signaling pathway 0.6695634882250727 1.4883704795283774 0.1366532173089547 1.0 0.747173718747776 6 P40763,P42224 2 |
| Histone modifications 0.6022125796880456 1.4870852080139054 0.1369923077747803 1.0 0.747173718747776 8 Q01105,Q96KQ7,Q9H7B4 3 |
| Cellular proteostasis 0.7258505382490599 1.4696313078326244 0.1416616362028677 1.0 0.747173718747776 4 Q9UHV9,Q99471 2 |
| Ketogenesis and ketolysis 0.6801596953902331 1.458056601403859 0.1448249422630909 1.0 0.747173718747776 5 O43772 1 |
| Microtubule cytoskeleton regulation 0.5094904344108518 1.4440883517785434 0.1487141242114709 1.0 0.747173718747776 13 P40763,Q13464,Q15691,Q9Y281,P06493 5 |
| Bdnftrkb signaling 0.6766803685760563 1.442675410103029 0.149111929322721 1.0 0.747173718747776 5 Q15418 1 |
| Disruption of postsynaptic signaling by cnv 0.6588380763861673 1.4394392866428118 0.1500261001055054 1.0 0.747173718747776 6 Q06787,Q7L576,P27361 3 |
| Metabolism of spingolipids in er and golgi apparatus 0.9317252657399844 1.3730850666415415 0.1697259029265212 1.0 0.747173718747776 2 Q06136 1 |
| Mitochondrial long chain fatty acid betaoxidation 0.5151873175785552 1.3722428364119426 0.169987854308159 1.0 0.747173718747776 12 P23786,O43772 2 |
| Acute viral myocarditis 0.5135223140884209 1.3623372651269972 0.1730914722702148 1.0 0.747173718747776 12 P40763,P11940,P27361,P78344,Q07812,Q04637,P42224 7 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.4952189075172032 1.3558624152857677 0.1751429479051474 1.0 0.747173718747776 13 O75822,P55010,O15372 3 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.6561578836879012 1.3517819132205022 0.176445091772651 1.0 0.747173718747776 5 P04792,P50570,Q9NR77 3 |
| Proteasome degradation 0.5918200481815413 1.3359677493289748 0.1815598148170716 1.0 0.747173718747776 41 P20618,O43242,P04844,P60900,Q99436,P28074,P28072,Q9UL46,P49721,P25787,O00231,P28070 12 |
| Aryl hydrocarbon receptor pathway wp2873 0.6500204666393784 1.324556776051175 0.1853182001768942 1.0 0.747173718747776 5 O00170,P07900,Q16543,Q15185 4 |
| Nucleotidebinding oligomerization domain nod pathway 0.689189524924527 1.3151721758427874 0.1884520440421018 1.0 0.747173718747776 4 Q13685,Q7L5N1 2 |
| Constitutive androstane receptor pathway 0.6467894151399516 1.3102188534156995 0.190121809510384 1.0 0.747173718747776 5 P08183 1 |
| Glutathione metabolism 0.6267334332381032 1.2924189228304062 0.1962121070326257 1.0 0.747173718747776 6 P11413,O75874,P28161 3 |
| Adipogenesis 0.4862193926485662 1.2737981662517248 0.2027349552278767 1.0 0.747173718747776 14 P40763,P14174,P49327,O75844,P43490,P06400,P42224 7 |
| Tgfbeta receptor signaling 0.6774387588048449 1.265574302715306 0.2056655310219521 1.0 0.747173718747776 4 P40763,P42224 2 |
| Tgfbeta receptor signaling in skeletal dysplasias 0.6774387588048449 1.265574302715306 0.2056655310219521 1.0 0.747173718747776 4 P40763,P42224 2 |
| Physicochemical features and toxicityassociated pathways 0.5284142745380948 1.2612602365119463 0.2072151024662334 1.0 0.747173718747776 10 P62993,P07737,P07197,P61586 4 |
| Male infertility 0.4975023557155067 1.2420954699501552 0.2142013397664572 1.0 0.747173718747776 18 P08183,P41440,Q15165 3 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.4973347400339675 1.241062566856018 0.2145826365748697 1.0 0.747173718747776 18 P37268,Q15392,Q16850 3 |
| Il6 signaling pathway 0.5363239920234526 1.2219113496753835 0.2217411529614081 1.0 0.7510070575144404 9 P40763,P62993,P42224 3 |
| Proximal tubule transport 0.5799082531982177 1.2152340120059355 0.2242768516468039 1.0 0.7510070575144404 7 P08183 1 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.6022023853204135 1.179817758016952 0.2380727051225337 1.0 0.7710505392388837 6 Q96KB5,P27361 2 |
| Ras and bradykinin pathways in covid19 0.6553022616819881 1.1721766950033536 0.2411261229794798 1.0 0.7721306451692636 4 P61586 1 |
| Dna replication 0.4960810447194665 1.1610903220070632 0.2456051700699839 1.0 0.7810889277849594 21 Q07864,P28340,P49643,P49736,P25205,P33993,Q14566,P41440,P15927 9 |
| Il17 signaling pathway 0.6475777207100738 1.1396304398044468 0.2544402980944193 1.0 0.7847474457017355 4 P40763 1 |
| Aryl hydrocarbon receptor pathway wp2586 0.5607994584311394 1.1221301161195425 0.2618071206541372 1.0 0.7952364575424584 7 Q16543,P06400,O00170,P07900,P48506 5 |
| Ferroptosis 0.4858408807899531 1.1218826262045354 0.2619123486445298 1.0 0.7952364575424584 20 P37268,P04792,P09601,P45880 4 |
| Sphingolipid pathway 0.5304763217606661 1.1160234297174207 0.2644121056877915 1.0 0.7986881130569372 8 Q96G23,Q06136 2 |
| Apoptosisrelated network due to altered notch3 in ovarian cancer 0.4564642935648021 1.0637747059926042 0.2874307723908766 1.0 0.8281046542533158 15 P08670,P04792 2 |
| Sphingolipid metabolism in senescence 0.491658253396301 1.0574096595314952 0.2903246649452837 1.0 0.8281046542533158 10 Q96G23 1 |
| Regulation of actin cytoskeleton 0.4898741486378741 1.054198977073474 0.2917918282850025 1.0 0.8281046542533158 24 P35241,Q9UQB8,P26038,Q13464,P35580,P41240,Q13177,P07737,P61586,P15311,P27361 11 |
| Mitochondrial complex iii assembly 0.5853585584640932 1.037989214933001 0.2992750762150442 1.0 0.8281046542533158 5 Q6DKK2 1 |
| Apoptosis modulation and signaling 0.5011854002332681 1.0336259538265904 0.3013110612882204 1.0 0.8281046542533158 9 Q9NR28 1 |
| Disorders of folate metabolism and transport 0.5421144792004693 1.03127123175892 0.302413645068617 1.0 0.8281046542533158 7 P00374 1 |
| Methionine metabolism leading to sulfur amino acids and related disorders 0.6162260425529724 1.0080831533469194 0.313414544477806 1.0 0.8309184683030426 4 Q99707 1 |
| Extracellular vesicles in the crosstalk of cardiac cells 0.712424120175538 0.9810442643717044 0.3265709137038013 1.0 0.8505358019130115 3 P04792 1 |
| Eicosanoid synthesis 0.8286999182338525 0.9724468378163748 0.3308283002734093 1.0 0.8517063553117684 2 P09960 1 |
| Nephrotic syndrome 0.4623598028879192 0.972099255673962 0.3310011724100175 1.0 0.8517063553117684 11 Q9NQW6,Q14108,O75844,P02545,P35579,O43707,Q9Y5K6 7 |
| Joubert syndrome 0.4307174661656928 0.9558452726188302 0.3391504117892729 1.0 0.8517063553117684 13 O43924 1 |
| Wnt signaling 0.4984912624509376 0.9505468101480704 0.3418344806435347 1.0 0.8517063553117684 8 Q13363 1 |
| Embryonic stem cell pluripotency pathways 0.4982715006134849 0.949414849215476 0.3424096609683986 1.0 0.8517063553117684 8 P40763 1 |
| Metapathway biotransformation phase i and ii 0.449706197991929 0.9244884195651014 0.3552320780700031 1.0 0.861356609120949 19 P07099,Q7LGA3 2 |
| Glycogen synthesis and degradation 0.4323960877934321 0.9156870230316396 0.359831073296134 1.0 0.8651713780387307 15 P13807,P0DP25,Q15257,P63151,P06737,P30154,P30153,P52789,P11216,Q16851 10 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.550321425078708 0.8846839116316481 0.3763271352023118 1.0 0.8673287520115582 5 P54619 1 |
| Mfap5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement 0.5493246009005328 0.8803646118961023 0.3786618207897794 1.0 0.8673287520115582 5 P12814,P18206,P28482,P27361 4 |
| Cell migration and invasion through p75ntr 0.8041700735895365 0.8799224946353074 0.3789012978070971 1.0 0.8673287520115582 2 P61586 1 |
| Agerage pathway 0.4214273479021176 0.8735392741404076 0.3823692091093513 1.0 0.8681580416664431 14 P40763,P26038,Q13464,P17931,P61586,P42224 6 |
| Sulfation biotransformation reaction 0.682617586912055 0.8675727133513453 0.3856282896023841 1.0 0.8691468373346043 3 P11413,O43252 2 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.4286960859824822 0.8577194757470894 0.3910473831652798 1.0 0.8697573444159727 12 Q32P28,O15460,P13674,Q96AY3,O75718 5 |
| Target of rapamycin tor signaling 0.541673444036857 0.8473117306859191 0.396821389819904 1.0 0.8697573444159727 5 Q96B36 1 |
| Cohesin complex cornelia de lange syndrome 0.4263495749989289 0.8439599403626216 0.398691791404214 1.0 0.8697573444159727 12 P30154,P30153,Q15257 3 |
| Translation factors 0.4954165243094008 0.8429485644105086 0.3992572110032366 1.0 0.8697573444159727 36 P29692,P49770,P55010,Q13144,Q15056,P11940,P60228,O75822,P06730,P05198,P23588,O15372,Q9NR50,O75153,P55884,Q14232 16 |
| Bile acids synthesis and enterohepatic circulation 0.6705168340611991 0.822173711034827 0.4109780385127215 1.0 0.8888819650492715 3 P51114 1 |
| Complement system in neuronal development and plasticity 0.5211004594224384 0.8114934062025472 0.4170823780017607 1.0 0.8888819650492715 6 Q9NR28 1 |
| Relationship between inflammation cox2 and egfr 0.6582880558487271 0.7767789175248799 0.4372892171791624 1.0 0.90973161928912 3 Q9H7Z7 1 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.524182061598544 0.7725136766234608 0.4398102497403569 1.0 0.90973161928912 5 Q9H3P2 1 |
| Mecp2 and associated rett syndrome 0.4114057479719047 0.7642714938193399 0.4447054692458434 1.0 0.90973161928912 16 P52597,P35637,P31943,P67809,Q13451 5 |
| Tca cycle nutrient use and invasiveness of ovarian cancer 0.6545071129778125 0.762852861397551 0.4455511514265826 1.0 0.90973161928912 3 P40763 1 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.5079206670887879 0.7532107543864422 0.4513232778466602 1.0 0.9147018922847264 6 P31943,Q8WUM4,P27361 3 |
| Camkk2 pathway 0.4835468396824784 0.7508283654405098 0.4527559560733589 1.0 0.9147018922847264 7 P09601,Q13501,O00429 3 |
| Eicosanoid metabolism via lipooxygenases lox 0.5178630611235097 0.7457970514154946 0.4557900214115018 1.0 0.9147018922847264 5 Q8N8N7 1 |
| Vitamin dsensitive calcium signaling in depression 0.5024856918886278 0.7293943305133893 0.4657604848282144 1.0 0.9255157174324724 6 Q8NB78 1 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.6384863540507167 0.7044857954600682 0.4811302929662422 1.0 0.9361868526887394 3 Q9BXK5 1 |
| Interleukin1 induced activation of nfkb 0.7510220768601833 0.6867490941470665 0.4922408537801934 1.0 0.9457480010334208 2 P61088 1 |
| Selenium micronutrient network 0.4317694799375771 0.669082134239633 0.5034430858715915 1.0 0.9565364569546344 9 Q8WTV0 1 |
| Hostpathogen interaction of human coronaviruses mapk signaling 0.4639596331474838 0.659955776553171 0.5092822091635596 1.0 0.9565364569546344 7 P51812 1 |
| Ncrnas involved in wnt signaling in hepatocellular carcinoma 0.4285492198836478 0.6527217861106536 0.5139356546991343 1.0 0.9591283237378748 9 Q13363 1 |
| Egfegfr signaling pathway 0.4395950927260345 0.6496585265170332 0.5159128190813131 1.0 0.9597616253385698 29 P30086,P40763,P00403,P62993,Q13464,P51812,Q15418,Q96J02,P42224 9 |
| Mbdnf and probdnf regulation of gaba neurotransmission 0.4822343831236135 0.6419983038177991 0.5208742843173013 1.0 0.9600015660878548 6 Q13464,P61586 2 |
| Sterol regulatory elementbinding proteins srebp signaling 0.4166359963002756 0.6389514540034126 0.5228545135123572 1.0 0.9600015660878548 23 Q15436,P48449,P14324,O95486,P37268,Q16850,Q9NR31,Q8WTV0 8 |
| Chemokine signaling pathway 0.3906649831824623 0.6387019139476462 0.5230168673808224 1.0 0.9600015660878548 12 P40763,P62993,Q13464,P41240,P42224 5 |
| Vitamin b12 metabolism 0.4786040669786596 0.6265866926714456 0.5309301935156638 1.0 0.9600015660878548 6 Q8WTV0 1 |
| Mirna biogenesis 0.6143149284253606 0.6186963066216489 0.5361164435696066 1.0 0.9600015660878548 3 Q9UPY3,P62826 2 |
| Prostaglandin and leukotriene metabolism in senescence 0.7289452166802985 0.6104689738324274 0.5415511899734802 1.0 0.9614997157222156 2 P09960 1 |
| Alzheimers disease 0.5426959831012478 0.6081323941400197 0.5430996687782481 1.0 0.9614997157222156 74 P20618,P60900,Q08752,Q9BVA1,Q99436,P07437,P21796,P28072,P28074,O95197,P68371,P49721,Q13885,P28070,P45880 15 |
| Fas ligand pathway and stress induction of heat shock proteins 0.3819669863986685 0.5902145419022462 0.5550468240559661 1.0 0.9738246673556769 12 P49327,Q9UNN5,P02545,Q13177,P06400,P04792 6 |
| Nucleotide excision repair 0.376903266487399 0.5852199424951134 0.5583998372373187 1.0 0.9745559931950012 15 P41440,P28340,P54727 3 |
| Parkinubiquitin proteasomal system pathway 0.4405469396289346 0.5801679722766576 0.561801349549655 1.0 0.9745559931950012 33 P62191,P68036,O43242,Q0VDF9,P17980,Q9BVA1,P07437,Q99460,Q9BUF5,P68371,P55036,Q13885,Q9UNM6,O00231,P0DMV9,P54652 16 |
| Alzheimers disease and mirna effects 0.5393450910199967 0.5797015259210798 0.5621159141636696 1.0 0.9745559931950012 75 P20618,P60900,Q08752,Q9BVA1,Q99436,P07437,P21796,P28072,P28074,O95197,P68371,P49721,Q13885,P28070,P45880 15 |
| Airway smooth muscle cell contraction 0.5037797753022814 0.5583570851024247 0.576600571268097 1.0 0.9793853181539272 4 P61586 1 |
| Familial hyperlipidemia type 4 0.7117743254292769 0.5531850304076324 0.5801367163672049 1.0 0.9797394399988624 2 Q9UBV2 1 |
| Lung fibrosis 0.4629458293408646 0.5232856050293254 0.6007755168542053 1.0 0.9942503868528816 5 P09601 1 |
| Micrornas in cardiomyocyte hypertrophy 0.3572461210094746 0.5189995430438903 0.6037610599078653 1.0 0.9942503868528816 13 P40763,Q13464,P61586,Q13144 4 |
| Melanoma 0.3903463940073693 0.5153512266327953 0.6063076082621948 1.0 0.9942503868528816 10 P0DP25,P62993,P06400,P11802,Q07812,P27361 6 |
| Tnfalpha signaling pathway 0.3602895112347415 0.5137755280092152 0.6074089394084157 1.0 0.9942503868528816 14 P06737,Q9NR28,P62993,Q16543,P07900,P27361 6 |
| G13 signaling pathway 0.3664270736499102 0.5056862815314933 0.6130769002659462 1.0 0.9998272191702674 12 Q13464,P07737,Q7L576,P61586 4 |
| Onecarbon metabolism 0.3543193877573207 0.5027013514616179 0.6151742593778782 1.0 0.9998272191702674 13 P00374 1 |
| Urea cycle and metabolism of amino groups 0.4060362853616838 0.4927147685509394 0.6222141409501165 1.0 0.9998272191702674 8 P54886 1 |
| Nonsmall cell lung cancer 0.385688771125714 0.492240427087162 0.6225493884276956 1.0 0.9998272191702674 10 P40763,P62993,P11802,P06400 4 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.4251926415717318 0.4878786341596953 0.6256358091214496 1.0 0.9998272191702674 7 P62993,P11802 2 |
| Integrinmediated cell adhesion 0.3484228396218179 0.470255247231384 0.6381726669547769 1.0 1.0 13 P62993,Q13464,Q13177,P41240 4 |
| Gammaglutamyl cycle for the biosynthesis and degradation of glutathione including diseases 0.5671487196055971 0.4615258322811234 0.6444213924081885 1.0 1.0 3 O75223 1 |
| P38 mapk signaling pathway 0.4423481354292883 0.4459023689759153 0.6556677709596064 1.0 1.0 5 P04792,P42224 2 |
| Nitric oxide metabolism in cystic fibrosis 0.4405928563390043 0.4395032437657286 0.6602969321498784 1.0 1.0 5 Q99873,O60678,Q86X55 3 |
| Cysteine and methionine catabolism 0.4224577203049984 0.4018465506056277 0.6877969608104846 1.0 1.0 6 Q99707 1 |
| Pparalpha pathway 0.4040423333476787 0.4000404690814533 0.6891267099120022 1.0 1.0 7 P23786,P06493,P02656 3 |
| Hepatitis b infection 0.3544107726327408 0.379792941019168 0.7040991226855207 1.0 1.0 19 P40763,P63104,P62993,Q15904,P27361,P42224 6 |
| Kit receptor signaling pathway 0.3396384583698851 0.3681022323364551 0.7127970064172118 1.0 1.0 12 P40763,P51812,Q15418,P42224 4 |
| Bmp signaling in eyelid development 0.64717906786591 0.3579919757355852 0.7203493185822114 1.0 1.0 2 P27361 1 |
| Base excision repair 0.3525309002158292 0.3363262069098117 0.736624889555245 1.0 1.0 10 P28340,P09429 2 |
| Transsulfuration pathway 0.4013608285674592 0.3260727447961932 0.7443693175522108 1.0 1.0 6 Q99707 1 |
| Heart development 0.4353518821603898 0.3250955066499948 0.7451087895944744 1.0 1.0 4 Q12948,P35222,P28482 3 |
| Atr signaling 0.6304170073589603 0.3136389323713179 0.7537952867064042 1.0 1.0 2 Q92547 1 |
| Netrinunc5b signaling pathway 0.337360568847534 0.3107479665019796 0.7559922291937686 1.0 1.0 11 P30154,P61586,Q15257 3 |
| Praderwilli and angelman syndrome 0.4179157522884031 0.2739937063989224 0.7840894582234417 1.0 1.0 4 Q7L576,P11802 2 |
| Burn wound healing 0.3539609682788536 0.2698597623005531 0.7872681440595135 1.0 1.0 8 Q99439,P08670,P09429,P31949 4 |
| Fluoropyrimidine activity 0.3176925919621799 0.2654334099532727 0.7906756014807819 1.0 1.0 12 P00374,P31350 2 |
| Purine metabolism 0.3682916837361636 0.2649936921413274 0.7910143211093179 1.0 1.0 7 P00491,P30520,P31939,P00492,P30566,P07741 6 |
| Chromosomal and microsatellite instability in colorectal cancer 0.3172353455871276 0.2634087282823544 0.7922355638930172 1.0 1.0 12 P61586,P43246 2 |
| Transsulfuration and onecarbon metabolism 0.3175915301315286 0.2564326574083296 0.797616773697309 1.0 1.0 16 P00374 1 |
| Angiopoietinlike protein 8 regulatory pathway 0.3311015051719964 0.2499746322597048 0.8026069664890929 1.0 1.0 20 P13807,P51812,Q15418,P06730,P41440,P54619,P27361 7 |
| Novel intracellular components of rigilike receptor rlr pathway 0.3613275455296991 0.2410323422511279 0.8095300498630467 1.0 1.0 7 Q13526 1 |
| Network map of sarscov2 signaling pathway 0.324277536513688 0.2359958303963764 0.8134359056701399 1.0 1.0 19 P31350,P06493,Q96AX1,Q96J02,P42224 5 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.3666384115543416 0.2152562133182073 0.8295675660865465 1.0 1.0 6 P49770,Q96B36 2 |
| Measles virus infection 0.3135523143739102 0.2057010459268585 0.8370244415005468 1.0 1.0 18 P40763,P67870,P49327,P26038,P05198,O15372,P0DMV9,P11802,P54652,P11142,P42224 11 |
| Pentose phosphate metabolism 0.3625001571885332 0.1951376142171989 0.8452852166654425 1.0 1.0 5 P11413 1 |
| Cell cycle 0.3819386120815889 0.1948454140810666 0.8455139682803514 1.0 1.0 39 P62258,Q9UJX4,Q9UJX2,P49736,P25205,P33991,P33993,O43683,Q14566,P06400,P06493,P11802,Q04917,P63104 14 |
| Ebsteinbarr virus lmp1 signaling 0.569910057236313 0.1795872688619938 0.8574766001567402 1.0 1.0 2 P07900 1 |
| Tolllike receptor signaling related to myd88 0.569910057236313 0.1795872688619938 0.8574766001567402 1.0 1.0 2 Q9H0E2 1 |
| Mfap5mediated ovarian cancer cell motility and invasiveness 0.5699100572363128 0.1795872688619935 0.8574766001567404 1.0 1.0 2 P27361 1 |
| Neovascularisation processes 0.5699100572363128 0.1795872688619935 0.8574766001567404 1.0 1.0 2 P27361 1 |
| Integrated cancer pathway 0.2909270821353859 0.17486892775615 0.86118262609436 1.0 1.0 14 P06493,P11802,P43246,P42224 4 |
| Envelope proteins and their potential roles in edmd physiopathology 0.294384395856067 0.1733700484725762 0.8623605664394249 1.0 1.0 15 P50402,P33176,P61586 3 |
| Cytosolic dnasensing pathway 0.3159961301681052 0.1371045155749106 0.8909481832651345 1.0 1.0 8 Q14258 1 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.346261134505066 0.1105555163050797 0.9119688240091116 1.0 1.0 4 P61201 1 |
| Thermogenesis 0.3100688476681545 0.1080603357304668 0.913947831359635 1.0 1.0 24 P23786,O43772,P51812 3 |
| 16p112 distal deletion syndrome 0.319748220248631 0.1026977003450985 0.9182028988542374 1.0 1.0 5 P62993,Q99873,P20339 3 |
| Thyroid stimulating hormone tsh signaling pathway 0.2713273210308047 0.0893505959500009 0.9288032850780764 1.0 1.0 15 P40763,Q15418,P06400,P11802,P42224 5 |
| Glycerophospholipid biosynthetic pathway 0.4024539877300616 0.0879722603595356 0.929898723667964 1.0 1.0 3 O95674,O00116 2 |
| G protein signaling pathways 0.2952328923426381 0.0780466310420118 0.9377909598821978 1.0 1.0 8 P61586 1 |
| Oxidative damage response 0.4897792313982102 0.0691349132280896 0.9448822307639192 1.0 1.0 2 P12004 1 |
| Sarscov2 b117 variant antagonises innate immune activation 0.4869174161897062 0.0665303359648921 0.9469556065978444 1.0 1.0 2 Q7Z434 1 |
| Dna repair pathways full network 0.3332474459855898 0.0510900401016017 0.9592537724769332 1.0 1.0 36 Q9BXW9,P54727,P28340,Q9UQ84,P12956,P41440,P15927,P09429,P43246 9 |
| Insulin signaling in adipocytes diabetic condition 0.3619631901840448 0.0474501328374534 0.9621544737625612 1.0 1.0 3 P42345,O60343 2 |
| Insulin signaling in adipocytes normal condition 0.3619631901840448 0.0474501328374534 0.9621544737625612 1.0 1.0 3 P42345,O60343 2 |
| Interactions between loxl4 and oxidative stress pathway 0.3148268808826379 0.021218682394813 0.9830712112412284 1.0 1.0 3 Q8TAG9 1 |
| Sarscov2 innate immunity evasion and cellspecific immune response 0.2640094988944627 0.0193114482946746 0.984592651213878 1.0 1.0 9 Q14258 1 |
| Mevalonate pathway 0.262274959083473 0.0188336470503112 0.984973812114018 1.0 1.0 4 Q9BWD1,P53602,P14324 3 |
| Peroxiredoxin 2 induced ovarian failure 0.3838920686835709 0.0170292050968102 0.9864133168493888 1.0 1.0 2 Q07812 1 |
| Liver x receptor pathway 0.3622240392477598 0.0139190835438341 0.9888945367380572 1.0 1.0 2 P49327 1 |
| Hypertrophy model 0.3013082583810388 0.0104818670953705 0.9916368332193748 1.0 1.0 2 P06730 1 |
| Vasopressinregulated water reabsorption 0.2305794644703079 0.0004452806197485 0.9996447174800184 1.0 1.0 13 P20339,Q9UJW0,O43237,Q13561,P52565,Q9Y6G9,Q14203 7 |
|
|
